Home  |  Contact

Cellosaurus H69R (CVCL_RS65)

[Text version]

Cell line name H69R
Accession CVCL_RS65
Resource Identification Initiative To cite this cell line use: H69R (RRID:CVCL_RS65)
Comments Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
Sequence variations Heterozygous for PIK3CA p.Gly106_Arg108del (c.317_325dellGGCAACCGT) (from parent cell line).
Homozygous for RB1 p.Glu748Ter (c.2242G>T) (from parent cell line).
Homozygous for TP53 p.Glu171Ter (c.511G>T) (ClinVar=VCV000634771) (from parent cell line).
Disease Lung small cell carcinoma (NCIt: C4917)
Small cell lung cancer (ORDO: Orphanet_70573)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1579 (NCI-H69)
Sex of cell Male
Age at sampling 55Y
Category Cancer cell line
Publications

PubMed=27610620; DOI=10.1371/journal.pone.0162925
Yan F., Pang J., Peng Y., Molina J.R., Yang P., Liu S.
Elevated cellular PD1/PD-L1 expression confers acquired resistance to cisplatin in small cell lung cancer cells.
PLoS ONE 11:E0162925-E0162925(2016)

Cross-references
Other Wikidata; Q54872207
Entry history
Entry creation05-Mar-2018
Last entry update02-Jul-2020
Version number5